ITCI vs. IYW
Compare and contrast key facts about Intra-Cellular Therapies, Inc. (ITCI) and iShares U.S. Technology ETF (IYW).
IYW is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Technology Index. It was launched on May 19, 2000.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ITCI or IYW.
Correlation
The correlation between ITCI and IYW is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ITCI vs. IYW - Performance Comparison
Key characteristics
ITCI:
1.39
IYW:
1.12
ITCI:
3.27
IYW:
1.55
ITCI:
1.40
IYW:
1.21
ITCI:
4.00
IYW:
1.55
ITCI:
8.62
IYW:
5.21
ITCI:
8.64%
IYW:
4.78%
ITCI:
53.73%
IYW:
22.35%
ITCI:
-87.64%
IYW:
-81.89%
ITCI:
0.00%
IYW:
-3.14%
Returns By Period
In the year-to-date period, ITCI achieves a 53.98% return, which is significantly higher than IYW's 1.27% return. Over the past 10 years, ITCI has underperformed IYW with an annualized return of 18.17%, while IYW has yielded a comparatively higher 20.36% annualized return.
ITCI
53.98%
1.14%
72.66%
78.78%
39.20%
18.17%
IYW
1.27%
-2.60%
8.27%
21.79%
21.33%
20.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ITCI vs. IYW — Risk-Adjusted Performance Rank
ITCI
IYW
ITCI vs. IYW - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and iShares U.S. Technology ETF (IYW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ITCI vs. IYW - Dividend Comparison
ITCI has not paid dividends to shareholders, while IYW's dividend yield for the trailing twelve months is around 0.21%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ITCI Intra-Cellular Therapies, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IYW iShares U.S. Technology ETF | 0.21% | 0.21% | 0.53% | 0.50% | 0.31% | 0.56% | 0.72% | 0.91% | 0.82% | 1.13% | 1.12% | 1.13% |
Drawdowns
ITCI vs. IYW - Drawdown Comparison
The maximum ITCI drawdown since its inception was -87.64%, which is greater than IYW's maximum drawdown of -81.89%. Use the drawdown chart below to compare losses from any high point for ITCI and IYW. For additional features, visit the drawdowns tool.
Volatility
ITCI vs. IYW - Volatility Comparison
The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.83%, while iShares U.S. Technology ETF (IYW) has a volatility of 7.27%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than IYW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.